Professor, Surgery-Massachusetts General Hospital, Harvard Medical School
General Surgery
Dr. James F. Markmann, MD
|
|
Give Review
James Markmann works in the field of General Surgery. He attended Perelman School of Medicine at the University of Pennsylvania. He has 4 awards "America's Top Doctors", "Boston Magazine", "Philadelphia Magazine" and "Fellow (FACS)". James Markmann is a published doctor. He published 100 publications, including: 'Socioeconomic gradients between locally transplanted and exported liver donors and recipients.' James Markmann accepts Medicare payments and is listed with Medicare.gov.
Publications
- Temporal Analysis of Market Competition and Density in Renal Transplantation Volume and Outcome.
- Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.
- Socioeconomic gradients between locally transplanted and exported Liver donors and recipients.
- Microfluidic mazes to characterize T-cell exploration patterns following activation in vitro.
- Human Neutrophils are Primed by ChemoatTractant Gradients for Blocking the Growth of Aspergillus fumigatus.
- The race to Liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
- Socioeconomic status and ethnicity of deceased donor kidney recipients compared to their donors.
- Successful long-term management of invasive cerebral fungal infection following Liver transplantation.
- Alginate Encapsulant Incorporating CXCL12 Supports Long-Term Allo- and Xenoislet Transplantation Without Systemic Immune Suppression.
- Immunogenicity of β-cells for autologous transplantation in type 1 diabetes.
- Monitoring of Allogeneic Islet Grafts in Nonhuman Primates Using MRI.
- Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site.
- Islet ProDuct Characteristics and Factors Related to Successful Human Islet Transplantation From the Collaborative Islet Transplant Registry (CITR) 1999-2010.
- Market competition influences renal transplantation risk and outcomes.
- Increased transfusion-free survival following auxiliary pig Liver xenotransplantation.
- Hepatic Retransplant: What Have We Learned?
- An immunosufficient murine model for the study of human islets.
- Multiple Listings as a Reflection of Geographic Disparity in Liver Transplantation.
- Subnormothermic Machine Perfusion for Ex Vivo Preservation and Recovery of the Human Liver for Transplantation.
- TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance.
- TIM4 regulates the anti-islet Th2 alloimmune response.
- The Migrated Liver Transplantation Candidate: Insight into Geographic Disparities in Liver Distribution.
- Successful Right Ventricular Mechanical Support after Combined Heart-Liver Transplantation.
- Age-related differences in hepatic ischemia/reperfusion: gene activation, Liver injury, and protective effect of melatonin.
- Immunosenescence and Immune Response in Organ Transplantation.
- Left accessory hepatic artery damage by a misplaced gastric band in a deceased Liver donor.
- HCC Patients Suffer Less From Geographic Differences in Organ Availability.
- Prophylaxis of hepatitis B infection in solid organ transplant recipients.
- Mechanisms of regulatory T cell counter-regulation by innate immunity.
- Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following Liver transplantation: a randomized controlled study.
- Transplantation: Are calcineurin inhibitors safer than mTOR inhibitors?
- Immune Rejection after Pancreatic Islet Cell Transplantation: In Vivo Dual Contrast-enhanced MR Imaging in a Mouse Model.
- Protein S deficiency in a living Liver donor.
- Inotuzumab Ozogamicin Murine Analog-Mediated B-Cell Depletion Reduces Anti-Islet Allo- and Autoimmune Responses.
- IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response.
- Therapeutic siRNA silencing in inflammatory monocytes in mice.
- Hyperlipidemia due to Biliary Stricture After Living-Donor Liver Transplantation.
- InDuction of diabetes with signs of autoimmunity in primates by the injection of multiple-low-dose streptozotocin.
- Inhibition of transplantation tolerance by immune senescence is reversed by endocrine modulation.
- A prospective, randomized comparison of bovine carotid artery and expanded polytetrafluoroethylene for permanent hemodialysis Vascular access.
- Alemtuzumab in kidney-transplant recipients.
- Renal allograft rupture: a strategy for graft preservation.
- Generation of adaptive regulatory T cells by alloantigen is required for some but not all transplant tolerance protocols.
- Geographic inequity in access to Livers for transplantation.
- GITR Blockade Facilitates Treg Mediated Allograft Survival.
- Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival.
- Transplant center volume and outcomes after Liver retransplantation.
- Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.
- Kidney transplantation at the University of Pennsylvania: 1998-2008.
- Donor age and cold ischemia interact to produce inferior 90-day Liver allograft survival.
- Tolerance: it's in your blood.
- Inhibition of ICAM-1/LFA-1 interactions prevents B-cell-dependent anti-CD45RB-induced transplantation tolerance.
- Availability of suitable islet donors in the United States.
- Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity.
- Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes.
- Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients.
- Salvage of nonmaturing native fistulas by using angioplasty.
- Progress toward antibody-induced transplantation tolerance.
- Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it.
- T-reg mediated suppression of the allograft response in the draining lymph node.
- Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular Cancer in the current MELD era.
- Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells.
- HLA sensitization in islet transplantation.
- Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes.
- Appendicitis among Liver transplant recipients.
- Renal function after orthotopic Liver transplantation is predicted by duration of pretransplantation creatinine elevation.
- Contrast-enhanced MR angiography for evaluation of Vascular complications of the pancreatic transplant.
- Pharmacologically regulated regeneration of functional human pancreatic islets.
- {beta}-Cell function following human islet transplantation for type 1 diabetes.
- Comparison of whole organ pancreas and isolated islet transplantation for type 1 diabetes.
- Expanded-criteria donor kidneys: a single-center clinical and short-term financial analysis--cause for concern in retransplantation.
- Survival among pediatric Liver transplant recipients: impact of segmental grafts.
- Transplantation for type I diabetes: comparison of Vascularized whole-organ pancreas with isolated pancreatic islets.
- Factors differentially correlated with the outcome of Liver transplantation in hcv+ and HCV- recipients.
- Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation.
- Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects.
- Early kidney dysfunction post liver transplantation predicts late chronic kidney Disease.
- TransDuction of human islets with pseudotyped lentiviral vectors.
- Predicting outcome after liver transplantation: utility of the model for end-stage liver Disease and a newly derived discrimination function.
- Survival following Liver transplantation from non-heart-beating donors.
- Homeostatic proliferation is a barrier to transplantation tolerance.
- Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity?
- Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells.
- Regulatory CD4+CD25+T cells in prevention of allograft rejection.
- Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival?
- Treatment of obstructive nephroureteral clot with a rheolytic mechanical thrombectomy device.
- Insulin independence following isolated islet transplantation and single islet infusions.
- The use of non-heart-beating donors for isolated pancreatic islet transplantation.
- Operative parameters that predict the outcomes of hepatic transplantation.
- CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance.
- Toward further expansion of the organ pool for adult Liver recipients: splitting the cadaveric Liver into right and left lobes.
- Pretransplant model to predict posttransplant survival in Liver transplant patients.
- Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomy.
- The outcome of Liver grafts procured from hepatitis C-positive donors.
- Obstructive jaundice caused by a giant non-parasitic hepatic cyst.
- Warm Ischemic Injury Is Reflected in the Release of Injury Markers during Cold Preservation of the Human Liver.
- Trends in the management and outcomes of kidney transplantation for autosomal dominant polycystic kidney Disease.
- Elevated Levels of Interferon-γ ProDuction by Memory T Cells Do Not Promote Transplant Tolerance Resistance in Aged Recipients.
- Historical overview of transplantation.
Schools
Perelman School of Medicine University of Pennsylvania
Hospital Of The University Of Pa
Procedures Preformed
- Arteriovenous Shunt Creation
- Colectomy
- Cystectomy
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- View All
Conditions Treated
- Abdominal Pain
- Atelectasis
- Bile Duct Cancer
- Biliary Atresia
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- Philadelphia Magazine
- Fellow (FACS)
Education
-
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1861422974 | |
| NPPES Provider LastName | MARKMANN | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 40.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861422974 |
| Last Name Of The Provider | MARKMANN |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Sidharth V. Puram, MD |
|
|
Dr. Erica M. Fallon, MD |
|
|
Dr. Marisa Cevasco, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roland A. Hernandez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judy Y. Chen, MD |
|
|
Dr. Ryan P. Cauley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Serguei Melnitchouk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joaquim M. Havens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Smita R. Ramanadham, MD |
|
|
Dr. Alan C. Sherburne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Nora Almana |